Cargando…

A metastatic G2 neuroendocrine tumor smaller than 5 mm: A case report

BACKGROUND: Neuroendocrine tumors (NETs) measuring <10 mm are widely thought to be at low risk of lymph node metastasis. Here we report a case of lymph node metastasis in a patient with a 4-mm NET that was classified as grade 2. PRESENTATION OF CASE: A 32-year-old woman was referred to our hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Manabu, Tsukamoto, Shunsuke, Moritani, Konosuke, Sekine, Hideki, Saito, Yutaka, Kanemitsu, Yukihide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038552/
https://www.ncbi.nlm.nih.gov/pubmed/35429783
http://dx.doi.org/10.1016/j.ijscr.2022.107037
_version_ 1784693948191604736
author Inoue, Manabu
Tsukamoto, Shunsuke
Moritani, Konosuke
Sekine, Hideki
Saito, Yutaka
Kanemitsu, Yukihide
author_facet Inoue, Manabu
Tsukamoto, Shunsuke
Moritani, Konosuke
Sekine, Hideki
Saito, Yutaka
Kanemitsu, Yukihide
author_sort Inoue, Manabu
collection PubMed
description BACKGROUND: Neuroendocrine tumors (NETs) measuring <10 mm are widely thought to be at low risk of lymph node metastasis. Here we report a case of lymph node metastasis in a patient with a 4-mm NET that was classified as grade 2. PRESENTATION OF CASE: A 32-year-old woman was referred to our hospital after a positive fecal occult blood test. Colonoscopy revealed a 4-mm yellowish submucosal tumor, which was diagnosed as NET of the upper rectum and removed by endoscopic submucosal resection with ligation. Pathological examination of the specimen showed a 4-mm grade 2 NET with a Ki-67 labeling index of 4.4% without lymphatic or venous invasion. In accordance with the European Neuroendocrine Tumor Society guidelines, we performed robotic-assisted laparoscopic low anterior resection with lymph node dissection. Final pathological examination revealed invasion confined to the submucosal layer and metastasis to one lymph node (pT1aN1M0, Stage IIIB). There were no residual tumor cells in the scar after endoscopic submucosal resection with ligation. DISCUSSION: Should G2 neuroendocrine tumors smaller than 5 mm be surgically resected? CONCLUSIONS: We encountered a rare case of a small NET with lymph node metastasis that was treated by robotic-assisted laparoscopic low anterior resection with lymph node dissection. Additional surgery is an option to be considered for grade 2 NET even if it is small because of the possibility of lymph node metastasis.
format Online
Article
Text
id pubmed-9038552
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90385522022-04-27 A metastatic G2 neuroendocrine tumor smaller than 5 mm: A case report Inoue, Manabu Tsukamoto, Shunsuke Moritani, Konosuke Sekine, Hideki Saito, Yutaka Kanemitsu, Yukihide Int J Surg Case Rep Case Report BACKGROUND: Neuroendocrine tumors (NETs) measuring <10 mm are widely thought to be at low risk of lymph node metastasis. Here we report a case of lymph node metastasis in a patient with a 4-mm NET that was classified as grade 2. PRESENTATION OF CASE: A 32-year-old woman was referred to our hospital after a positive fecal occult blood test. Colonoscopy revealed a 4-mm yellowish submucosal tumor, which was diagnosed as NET of the upper rectum and removed by endoscopic submucosal resection with ligation. Pathological examination of the specimen showed a 4-mm grade 2 NET with a Ki-67 labeling index of 4.4% without lymphatic or venous invasion. In accordance with the European Neuroendocrine Tumor Society guidelines, we performed robotic-assisted laparoscopic low anterior resection with lymph node dissection. Final pathological examination revealed invasion confined to the submucosal layer and metastasis to one lymph node (pT1aN1M0, Stage IIIB). There were no residual tumor cells in the scar after endoscopic submucosal resection with ligation. DISCUSSION: Should G2 neuroendocrine tumors smaller than 5 mm be surgically resected? CONCLUSIONS: We encountered a rare case of a small NET with lymph node metastasis that was treated by robotic-assisted laparoscopic low anterior resection with lymph node dissection. Additional surgery is an option to be considered for grade 2 NET even if it is small because of the possibility of lymph node metastasis. Elsevier 2022-04-05 /pmc/articles/PMC9038552/ /pubmed/35429783 http://dx.doi.org/10.1016/j.ijscr.2022.107037 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Inoue, Manabu
Tsukamoto, Shunsuke
Moritani, Konosuke
Sekine, Hideki
Saito, Yutaka
Kanemitsu, Yukihide
A metastatic G2 neuroendocrine tumor smaller than 5 mm: A case report
title A metastatic G2 neuroendocrine tumor smaller than 5 mm: A case report
title_full A metastatic G2 neuroendocrine tumor smaller than 5 mm: A case report
title_fullStr A metastatic G2 neuroendocrine tumor smaller than 5 mm: A case report
title_full_unstemmed A metastatic G2 neuroendocrine tumor smaller than 5 mm: A case report
title_short A metastatic G2 neuroendocrine tumor smaller than 5 mm: A case report
title_sort metastatic g2 neuroendocrine tumor smaller than 5 mm: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038552/
https://www.ncbi.nlm.nih.gov/pubmed/35429783
http://dx.doi.org/10.1016/j.ijscr.2022.107037
work_keys_str_mv AT inouemanabu ametastaticg2neuroendocrinetumorsmallerthan5mmacasereport
AT tsukamotoshunsuke ametastaticg2neuroendocrinetumorsmallerthan5mmacasereport
AT moritanikonosuke ametastaticg2neuroendocrinetumorsmallerthan5mmacasereport
AT sekinehideki ametastaticg2neuroendocrinetumorsmallerthan5mmacasereport
AT saitoyutaka ametastaticg2neuroendocrinetumorsmallerthan5mmacasereport
AT kanemitsuyukihide ametastaticg2neuroendocrinetumorsmallerthan5mmacasereport
AT inouemanabu metastaticg2neuroendocrinetumorsmallerthan5mmacasereport
AT tsukamotoshunsuke metastaticg2neuroendocrinetumorsmallerthan5mmacasereport
AT moritanikonosuke metastaticg2neuroendocrinetumorsmallerthan5mmacasereport
AT sekinehideki metastaticg2neuroendocrinetumorsmallerthan5mmacasereport
AT saitoyutaka metastaticg2neuroendocrinetumorsmallerthan5mmacasereport
AT kanemitsuyukihide metastaticg2neuroendocrinetumorsmallerthan5mmacasereport